IBB News and Press, iShares Biotechnology ETF From 10/06/25

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...

2025-10-02 10:40:39 ET Top 5 S&P 500 healthcare performers in Q3: Incyte (NASDAQ: INCY ) +23.40% AbbVie (NYSE: ABBV ) +21.63% J&J ( JNJ ) +19.48% West Pharmaceutical (NYSE: WST ) +18.97% IQVIA (NYSE: IQV ) +16.81% Bottom 5 S&P 500 heal...

2025-10-01 18:05:05 ET The iShares Biotechnology ETF And A History Of The Industry Since the middle part of the 20th century, the biotech industry has grown from a fringe segment of healthcare to a vital part of innovation. It stands at the crossroads of health and technology. Here'...

2025-09-30 12:30:00 ET The September 2025 edition of the S&P 500 equity sector rotation chartbook can be found here . You can read more about the methodology and underlying assets here . This chartbook has been prepared with 1y total return, which is a departure from the first v...

2025-09-25 14:00:30 ET More on Amgen, iShares Biotechnology ETF, etc. Amgen: Imdelltra Could Be The Next Game Changer Amgen: Buy The Dip Opportunity XLV: Market Overreaction Could Drive Double Digit Shareholder Yield Notable healthcare headlines for the week:...

2025-09-24 10:17:30 ET It's been just over three months since my last article on Amgen Inc. (AMGN), "Amgen: Imdelltra Data and Q1 Results Impressive."... Read the full article on Seeking Alpha For further details see: Amgen: Imdelltra Could Be The Next Game Changer

2025-09-24 02:40:00 ET By Vinay Thapar, CFA and Jane Bleeg AI is a potential boon to healthcare companies, but business fundamentals - not the latest science - are the true test of staying power. ... Read the full article on Seeking Alpha For further details see:...

2025-09-16 14:55:56 ET More on iShares Biotechnology ETF BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI Short bets on S&P 500 Healthcare sector eases in August; MRNA stays most s...

2025-09-15 09:35:55 ET More on The Health Care Select Sector SPDR® Fund ETF XLV: Market Overreaction Could Drive Double Digit Shareholder Yield XLV Vs. IHE: Will Pharmaceuticals Outperform Healthcare? XLV: Life Expectancy, Patents, And A Positive Outlook Will Pa...

2025-09-12 11:30:00 ET Pharma and biotech stocks have struggled lately as uncertainty over the potential impact of tariffs and pricing pressures. Jasper Hellweg, Security Analyst with Argus Research, joins MoneyTalk to discuss how new treatment types and U.S. policy changes could be cat...